Krka d.d. | Balance Sheet

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
68
24
48
39
46
123
Total Accounts Receivable
482
516
502
554
523
483
Inventories
236
246
273
281
311
365
Other Current Assets
-
-
-
-
5
4
Total Current Assets
786
787
823
873
885
974
Net Property, Plant & Equipment
824
846
826
874
865
839
Total Investments and Advances
5
7
8
10
9
9
Long-Term Note Receivable
6
7
8
9
11
11
Intangible Assets
116
120
117
114
111
110
Other Assets
-
-
-
-
-
-
Total Assets
1,760
1,796
1,811
1,914
1,921
1,985
ST Debt & Current Portion LT Debt
-
38
-
-
-
Accounts Payable
131
115
104
128
108
Income Tax Payable
7
1
8
2
16
Other Current Liabilities
160
164
180
222
186
Total Current Liabilities
298
318
292
352
310
Provision for Risks & Charges
103
97
85
91
98
Deferred Taxes
10
14
15
19
26
Other Liabilities
-
-
-
-
-
Total Liabilities
414
429
392
458
422
Common Equity (Total)
1,331
1,351
1,405
1,443
1,487
Total Shareholders' Equity
1,331
1,351
1,405
1,443
1,487
Total Equity
1,333
1,352
1,406
1,444
1,488
Liabilities & Shareholders' Equity
1,760
1,796
1,811
1,914
1,921
Accumulated Minority Interest
1
1
1
1
1
Non-Equity Reserves
13
15
13
12
11

About Krka

View Profile
Address
Šmarješka cesta 6
Novo Mesto NM 8501
Slovenia
Employees -
Website http://www.krka.biz
Updated 07/08/2019
KRKA dd is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of human and animal health products. It operates through the following geographical segments: European Union, South-East Europe, and Eastern Europe. The European Union segment includes all countries of the European Union.